ANA MARIA LASTRA QUEIPO-rekin lankidetzan egindako argitalpenak (8)

2020

  1. A low pKa ligand inhibits cancer-associated pain in mice by activating peripheral mu-opioid receptors

    Scientific Reports, Vol. 10, Núm. 1

  2. Dual dose-related effects evoked by CCL4 on thermal nociception after gene delivery or exogenous administration in mice

    Biochemical Pharmacology, Vol. 175

2017

  1. Hyperalgesic and hypoalgesic mechanisms evoked by the acute administration of CCL5 in mice

    Brain, Behavior, and Immunity, Vol. 62, pp. 151-161

  2. Synergistic combinations of the dual enkephalinase inhibitor PL265 given orally with various analgesic compounds acting on different targets, in a murine model of cancer-induced bone pain

    Scandinavian Journal of Pain, Vol. 14, pp. 25-38

2016

  1. Analgesic effects evoked by a CCR2 antagonist or an anti-CCL2 antibody in inflamed mice

    Fundamental and Clinical Pharmacology, Vol. 30, Núm. 3, pp. 235-247

  2. Involvement of CC Chemokine Receptor 1 and CCL3 in Acute and Chronic Inflammatory Pain in Mice

    Basic & clinical pharmacology & toxicology, Vol. 119, Núm. 1, pp. 32-40

2014

  1. Involvement of spinal chemokine ccl2 in the hyperalgesia evoked by bone cancer in mice: A role for astroglia and microglia

    Cellular and Molecular Neurobiology, Vol. 34, Núm. 1, pp. 143-156

2012

  1. CCL2 released at tumoral level contributes to the hyperalgesia evoked by intratibial inoculation of NCTC 2472 but not B16-F10 cells in mice

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 385, Núm. 11, pp. 1053-1061